VistaGen Therapeutics
VTGN
VTGN
52 hedge funds and large institutions have $127M invested in VistaGen Therapeutics in 2020 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 4 closing their positions.
Holders
52
Holders Change
+24
Holders Change %
+85.71%
% of All Funds
0.92%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
28
Increased
8
Reduced
4
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
VA
1
VR Adviser
New York
|
$18.2M |
| 2 |
NMC
2
NEA Management Company
Timonium,
Maryland
|
$18.2M |
| 3 |
O
3
OrbiMed
New York
|
$14.6M |
| 4 |
ACP
4
Acuta Capital Partners
Redwood City,
California
|
$14.6M |
| 5 |
5
Franklin Resources
San Mateo,
California
|
$12.1M |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
Wells Fargo
San Francisco,
California
| $1K | 421 | – | – |
|
52
HighTower Advisors
Chicago,
Illinois
| – | – | -132,328 | Closed |
|
|
RC
53
RBF Capital
San Francisco,
California
| – | – | -25,000 | Closed |
|
|
TRCT
54
Tower Research Capital (TRC)
New York
| – | – | -18,943 | Closed |
|
55
Commonwealth Equity Services
Waltham,
Massachusetts
| – | – | -13,195 | Closed |
|
|
CFGS
56
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
|
GI
57
Gradient Investments
Arden Hills,
Minnesota
| $0 | 25 | – | – |
|